A proposed cleaning classification system for reusable medical devices to complement the Spaulding classification

Autor: Kremer, T., Rowan, N.J., McDonnell, G.

Publikováno v: In Journal of Hospital Infection March 2024 145:88-98

COVID-19 in Multiple Sclerosis: Clinically reported outcomes from the UK Multiple Sclerosis Register

Autor: Middleton, RM, Craig, EM, Rodgers, WJ, Tuite-Dalton, K, Garjani, A, Evangelou, N, das Nair, R, Hunter, R, Tallantyre, EC, Cauchi, M, Cairn, C, Paling, D, Fuller, S, McDonnell, G, Petheram, K, Liu, B, Nock, U, Ingram, G, Brownlee, W, Taylor, J, Nicholas, R

Publikováno v: In Multiple Sclerosis and Related Disorders November 2021 56

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.

Autor: Blackstone J; Comprehensive Clinical Trials Unit, University College London, London, UK., Williams T; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK., Nicholas JM; Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK., Bordea E; Comprehensive Clinical Trials Unit, University College London, London, UK., De Angelis F; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK., Bianchi A; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK., Calvi A; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK., Doshi A; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK., John N; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK., Apap Mangion S; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK., Wade C; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK., Merry R; Comprehensive Clinical Trials Unit, University College London, London, UK., Barton G; Comprehensive Clinical Trials Unit, University College London, London, UK., Lyle D; Anne Rowling Regenerative Neurology Clinic, NHS Lothian, Edinburgh, UK., Jarman E; University Hospital Southampton NHS Foundation Trust, Southampton, UK., Mahad D; Anne Rowling Regenerative Neurology Clinic, NHS Lothian, Edinburgh, UK., Shehu A; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK., Arun T; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK., McDonnell G; Belfast City Hospital Health and Social Services Trust, Belfast, UK., Geraldes R; Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Craner M; Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Hillier C; University Hospitals Dorset NHS Foundation Trust, Poole, UK., Ganesalingam J; University Hospitals Sussex NHS Foundation Trust, Brighton, UK., Fisniku L; University Hospitals Sussex NHS Foundation Trust, Brighton, UK., Hobart J; University Hospitals Plymouth NHS Trust, Plymouth, UK., Spilker C; Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK., Robertson N; University Hospital of Wales, Cardiff, UK., Kalra S; University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK., Pluchino S; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; University of Cambridge, Cambridge, UK., Harikrishnan S; East Kent Hospitals University NHS Foundation Trust, Canterbury, UK., Mattoscio M; Barking Havering and Redbridge University Hospitals NHS Trust, Romford, UK., Harrower T; Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK., Young C; The Walton Centre NHS Foundation Trust, Liverpool, UK.; Institute of Systems Molecular and Integrative Biology, University of Liverpool, Liverpool, UK., Lee M; Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK., Chhetri S; Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK., Ahmed F; Hull University Teaching Hospitals NHS Trust, Hull, UK., Rog D; Department of Neurology, Salford Royal NHS Foundation Trust, Salford, UK., Silber E; Department of Neurology, Lewisham and Greenwich NHS Trust, London, UK., Gallagher P; Queen Elizabeth University Hospital, Glasgow, UK., Duddy M; Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK., Straukiene A; Torbay and South Devon NHS Foundation Trust, Torquay, UK., Nicholas R; Imperial College Healthcare NHS Trust, London, UK., Rice C; North Bristol NHS Trust, Bristol, UK., Nixon SJ; MS Society, London, UK., Beveridge J; MS Society, London, UK., Hawton A; University of Exeter, Exeter, UK., Tebbs S; Comprehensive Clinical Trials Unit, University College London, London, UK., Braisher M; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK., Giovannoni G; Blizard Institute, Queen Mary University, London, UK., Ciccarelli O; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK., Greenwood J; Institute of Ophthalmology, University College London, London, UK., Thompson AJ; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK., Hunter R; Department of Primary Care and Population Health, University College London Research, London, UK., Pavitt S; University of Leeds, Leeds, UK., Pearson O; Swansea Bay UHB, Swansea, UK., Evangelou N; Nottingham University Hospitals NHS Trust, Nottingham, UK., Sharrack B; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Galea I; Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton, UK., Chandran S; Anne Rowling Regenerative Neurology Clinic, NHS Lothian, Edinburgh, UK.; Division of Clinical and Surgical Sciences, University of Edinburgh, Edinburgh, UK., Ford HL; Centre for Neurosciences, Leeds General Infirmary, Leeds, UK., Frost C; Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK., Chataway J; Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK j.chataway@ucl.ac.uk.; National Institute for Health Research, Biomedical Research Centre, University College London Hospitals, London, UK.

Publikováno v: BMJ open [BMJ Open] 2024 Sep 16; Vol. 14 (9), pp. e086414. Date of Electronic Publication: 2024 Sep 16.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Science and the Environment of Man R. G. Cull K. S. McDonnell G. R. Meyer

Publikováno v: The American Biology Teacher, 1968 Apr 01. 30(4), 332-332.

Externí odkaz: https://www.jstor.org/stable/4442074